IP Library Granted Patent US 7,276,552
Granted Patent B2
US 7,276,552 · App. 11/273,778 · Granted Oct 2, 2007

Compositions and methods for inhibiting protein on surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,276,552
App. No.
11/273,778
Granted
Oct 2, 2007
Kind
B2
Abstract

The use of NIPAM polymers to prevent or reduce the formation of protein deposits on the surfaces of medical devices is described. The invention is particularly directed to reduction of the adsorption of proteins on surfaces of contact lenses and other medical prosthetics.

Claims (3)

1. A sterile, aqueous solution for treating contact lenses, comprising: (a) an amount of a NIPAM polymer effective to inhibit the formation of protein deposits on said lenses and sufficient to provide said solution with a surface tension of less than 50 mnM −1 at a temperature of 23° C.; (b) an ophthalmically acceptable vehicle for said NIPAM polymer; and (c) an opthalmically acceptable antimicrobial agent in an amount effective to disinfect contact lenses, said solution having a physiologically compatible pH and an osmolality of 200 to 400 mOsm/kg, characterized in that, when said solution is applied to the surfaces of a contact lens, the adsorption of lysozyme to said surfaces following such application is inhibited.

2. The solution of claim 1 wherein the solution contains the NIPAM polymer in an amount sufficient to provide the solution with a surface tension of less than 50 mNm −1 at a temperature of 23° C.

3. The solution of claim 1 wherein the solution is a multi-purpose solution suitable for treating contact lenses on a daily basis, and further comprises an effective amount of a surfactant.

Assignments (1)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →